Skip to main content

Table 2 Association of 40F and 43E with thymidine analogue-associated mutations

From: Identification of a novel resistance (E40F) and compensatory (K43E) substitution in HIV-1 reverse transcriptase

pos1

pos2

phi

OR

% pos2 in pos1

P value

40F

43E

0.287

38.2

84%

<10E-09

40F

41L

0.125

6.9

99%

<10E-09

40F

210W

0.162

11.2

97%

<10E-09

40F

215Y

0.124

7.2

94%

<10E-09

40F

67N

0.107

6.6

79%

<10E-09

40F

70R

0.001

1.1

9%

NS

40F

215F

-0.001

0.9

4%

NS

40F

219E

0.032

4.6

14%

<10E-09

40F

219Q

-0.003

0.8

4%

NS

43E

40F

0.287

38.2

10%

<10E-09

43E

41L

0.326

6.3

91%

<10E-09

43E

210W

0.367

9.0

78%

<10E-09

43E

215Y

0.31

6.4

82%

<10E-09

43E

67N

0.211

4.8

58%

<10E-09

43E

70R

-0.002

0.9

9%

NS

43E

215F

0.014

1.4

7%

9.7E-08

43E

219E

0.009

1.4

4%

NS

43E

219Q

0.004

1.1

6%

NS

  1. Binomial correlation coefficients (phi) and Odds Ratios (OR) were calculated for 57 amino acid substitutions at 34 reverse transcriptase codons to study the association of E40F and K43E with each other and with known thymidine analogue associated mutations.
  2. Phi: binomial correlation coefficient (1.0 = perfect pairwise correlation). OR: Odds Ratio – the observed frequency of the pair divided by the product of the individual mutation frequencies. P-value: chisquare probability was evaluated for significance at a Benjamini-Hochberg false discovery rate (FDR) of 0.01 for 1,566 multiple comparisons.
  3. NS: Not significant at FDR 0.01.
  4. Sequences with a phi value of 0.15 or greater, an odds ratio of > 2 and FDR of 0.01 were considered to be co-varying.